Molecular prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori in the United Arab Emirates

Saudi Med J. 2005 May;26(5):763-6.

Abstract

Objective: The aim of the study was to find the prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori (H. pylori) in the United Arab Emirates.

Methods: Gastric biopsy samples were obtained from 9 dyspeptic patients attending the endoscopy department in Zayed Military Hospital, Abu-Dhabi, UAE during the period from January to September 2004. Real-time polymerase chain reaction (PCR) was carried out for these biopsies to determine the point mutations.

Results: Of the 55 (60%) real-time biopsies that were PCR positive for H. pylori, 36 (65.5%) were found to have mutant genes. The A(2142/43)G mutation was more common (63.6%) than the A(2142)C mutation (18.2%).

Conclusion: Point mutations A(2442/43)G and A(2142)C and the combination of both were common among our patients. Perhaps the highest reported yet. Mutation at A(2142/43)G is far more common than mutation at A(2142)C.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biopsy
  • Clarithromycin / pharmacology*
  • Drug Resistance, Microbial / genetics*
  • Female
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / genetics
  • Humans
  • Male
  • Point Mutation / genetics*
  • Polymerase Chain Reaction
  • Prevalence
  • RNA, Bacterial / genetics
  • RNA, Ribosomal, 23S / genetics
  • Saudi Arabia / epidemiology
  • Stomach Neoplasms / genetics

Substances

  • Anti-Bacterial Agents
  • RNA, Bacterial
  • RNA, Ribosomal, 23S
  • Clarithromycin